Manufacturer:

Genentech

Name:

TECENTRIQ

Category:

J Code

HCPCS:

J9022

NDC(s):

50242-0917-01, 50242-0918-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

TECENTRIQ is a Cancer drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9022 is aligned to the drug TECENTRIQ.